The Zantac recall was issued on October 11th, after several people became ill. The company is manufactured by Sanofi Aventis, and the majority of their product lines are composed of generic medications. A number of people became extremely ill, and in some instances their symptoms were so severe that they had to be hospitalized. All but one of the victims were children, all of whom later died. You'll want to learn more about pharma lawsuits.
In a nutshell, the recall affects Zantac, generic naproxen, and generic napsafe. Zantac is marketed under various names, including Clearasil, Zantac plus, and Maxoderm. The drug is distributed through a variety of distributors, including such well known companies as AstraZeneca, GlaxoSmithKline, Cepacol, and Jansport. The distributors are responsible for providing the samples of generic drugs that have been ordered by retailers. When problems with these samples arise, it falls to the distributor to contact the manufacture and request that they return the drugs for a replacement.
Zantac's recall affects about twenty different generic doses of naproxen, as well as two additional brands: Decongestant and Maxolon. Decongestant is marketed under the brand name of Norpramin, while Maxolon is sold under the brand name of Actonel. The manufacturer of Norpramin is Lorsban Inc., which is listed as a distributor on the FDA's website as well. It is believed that these medications contributed to the outbreak of nausea and vomiting, which began just before the recall.
The Zantac recall affects three separate groups: those who have taken the medicine within the past two months; those who have taken the medicine within the past three months; and those who have taken the medicine within the last seven days. However, it does not appear that these people met the guidelines required for taking these medications as instructed, which are to take the medicine with meals. In addition, the medicines were being distributed only to pharmacies who are members of the Zantac system, and only to pharmacies in the United States. Those who have taken the medicine within the past seven days and have a peptic ulcer will not be covered by this recall.
This recall includes all products manufactured by Zantac Pharmaceuticals, including Dr. Reddy Organics, Noval Systems, and Jansport. The company producing the drug, Alliomex, holds the exclusive rights to produce and distribute the product within the United States. This includes all of the Octogenix tablets, which are manufactured by Jansport. Do view here for more insight into lawsuits today.
The company producing the antihistamine drug, Benadryl, is also included in the recall. The recalled lot numbers for the benadryl range from CFMEA to BEA. Also, the code for the number of tablets that are being recalled is different for the different products. Specifically, the lot number for the ranitidine tablets is 5000 individually ordered for sale, while the lot number for the octogenix tablets is 1015.
